Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-044022
Filing Date
2024-04-12
Accepted
2024-04-12 16:05:03
Documents
4
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 PRE 14A hlvx-preliminary-proxy-2.htm PRE 14A 647998
2 GRAPHIC img248031861_0.jpg GRAPHIC 24699
3 GRAPHIC img248031861_1.jpg GRAPHIC 24699
4 GRAPHIC img248031861_2.jpg GRAPHIC 24699
  Complete submission text file 0000950170-24-044022.txt   751520
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41365 | Film No.: 24841427
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)